DSGN logo

Design Therapeutics (DSGN) Company Overview

Profile

Full Name:

Design Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 29, 2021

Indexes:

Not included

Description:

Design Therapeutics is a biotechnology company focused on developing innovative treatments for genetic diseases. They use advanced design techniques to create therapies that target the underlying causes of these conditions, aiming to improve patients' lives through effective and personalized medical solutions.

Events Calendar

Earnings

Next earnings date:

Mar 19, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 19, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Aug 6, 24 RBC Capital
Sector Perform
May 7, 24 Piper Sandler
Overweight
Mar 20, 24 Wedbush
Neutral
Mar 20, 24 RBC Capital
Sector Perform
Nov 14, 23 RBC Capital
Sector Perform
Aug 15, 23 Wedbush
Neutral
Aug 15, 23 SVB Leerink
Market Perform
Aug 15, 23 RBC Capital
Sector Perform
May 10, 23 Wedbush
Outperform
May 10, 23 RBC Capital
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Design Therapeutics?
  • Does Design Therapeutics pay dividends?
  • What sector is Design Therapeutics in?
  • What industry is Design Therapeutics in?
  • What country is Design Therapeutics based in?
  • When did Design Therapeutics go public?
  • Is Design Therapeutics in the S&P 500?
  • Is Design Therapeutics in the NASDAQ 100?
  • Is Design Therapeutics in the Dow Jones?
  • When was Design Therapeutics's last earnings report?
  • When does Design Therapeutics report earnings?
  • Should I buy Design Therapeutics stock now?

What is the ticker symbol for Design Therapeutics?

The ticker symbol for Design Therapeutics is NASDAQ:DSGN

Does Design Therapeutics pay dividends?

No, Design Therapeutics does not pay dividends

What sector is Design Therapeutics in?

Design Therapeutics is in the Healthcare sector

What industry is Design Therapeutics in?

Design Therapeutics is in the Biotechnology industry

What country is Design Therapeutics based in?

Design Therapeutics is headquartered in United States

When did Design Therapeutics go public?

Design Therapeutics's initial public offering (IPO) was on March 29, 2021

Is Design Therapeutics in the S&P 500?

No, Design Therapeutics is not included in the S&P 500 index

Is Design Therapeutics in the NASDAQ 100?

No, Design Therapeutics is not included in the NASDAQ 100 index

Is Design Therapeutics in the Dow Jones?

No, Design Therapeutics is not included in the Dow Jones index

When was Design Therapeutics's last earnings report?

Design Therapeutics's most recent earnings report was on Nov 7, 2024

When does Design Therapeutics report earnings?

The next expected earnings date for Design Therapeutics is Mar 19, 2025

Should I buy Design Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions